Express Reports Wider Loss in Q3
Express reports a wider loss in Q3 but achieves 5% sales growth due to Bonobos acquisition. Online sales increase while retail store performance declines.
Nutanix Raises Revenue Outlook
Nutanix raises its fiscal-year revenue outlook and contract value billings forecast, with strong cash flow expectations. Also, exceeds projections for fiscal second quarter revenue. Strengthened partnerships with Cisco.
Higher Pay and Benefits Impact Auto Prices
Rise in wages and benefits will add $500 to car prices by 2024, with EVs seeing additional $200-$300 increase. Impact on car buyers minimal. GM's profitability remains unaffected. Labor agreements to add $1.5-$2.0 billion in costs over four...
Boeing Stock Gets a Boost as Analyst Upgrades and Predicts Growth
An analyst upgrades Boeing stock and predicts increased commercial jet deliveries, leading to positive market outlook.
U.S. Stocks Set for Subdued Open as Investors Await Fed Meeting Minutes
U.S. stocks are expected to open with little fanfare on Monday as investors eagerly anticipate the release of the Federal Reserve's meeting minutes. This article provides an overview of upcoming earnings announcements and economic events fo...
Tammy Faye Messner: A Broadway Musical
The highly anticipated Broadway musical 'Tammy Faye' tells the story of Tammy Faye Messner and her rise to fame, scandal, and redemption. With music by Elton John and positive reviews, this show is set to captivate audiences.
Train Derails in Southwest Michigan
A train derails in Southwest Michigan, causing non-life threatening injuries to the engineer and passengers. Investigation ongoing. Several trains between Chicago and Michigan communities canceled.
Exploring New Nuclear Power in Sweden
Finnish utility Fortum and Swedish nuclear technology company Studsvik are teaming up to explore the possibility of new nuclear power in Sweden. The focus is on assessing the potential for small modular reactors or conventional large reacto...
Homology Medicines Receives Buyout Offer from Q32 Bio
Homology Medicines receives a buyout offer from Q32 Bio, leading to a strategic merger focused on autoimmune and inflammatory diseases. The merged company will prioritize the advancement of Q32 Bio's clinical development candidates, backed...
Challenges for Plug Power as Stock Faces Downgrade on Wall Street
Plug Power's stock faces challenges including a downgrade, liquidity issues, and the need for more funding. Despite potential funding solutions, cautionary outlook remains.